HUE053063T2 - Nikotin-tartalmú szilárd dózisforma csökkentett organoleptikusan zavaró hatással - Google Patents
Nikotin-tartalmú szilárd dózisforma csökkentett organoleptikusan zavaró hatássalInfo
- Publication number
- HUE053063T2 HUE053063T2 HUE13733926A HUE13733926A HUE053063T2 HU E053063 T2 HUE053063 T2 HU E053063T2 HU E13733926 A HUE13733926 A HU E13733926A HU E13733926 A HUE13733926 A HU E13733926A HU E053063 T2 HUE053063 T2 HU E053063T2
- Authority
- HU
- Hungary
- Prior art keywords
- disturbance
- dosage form
- solid nicotine
- reduced organoleptic
- organoleptic
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Addiction (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1200017 | 2012-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE053063T2 true HUE053063T2 (hu) | 2021-06-28 |
Family
ID=48744083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13733926A HUE053063T2 (hu) | 2012-01-05 | 2013-01-07 | Nikotin-tartalmú szilárd dózisforma csökkentett organoleptikusan zavaró hatással |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130177646A1 (hu) |
| EP (1) | EP2800557B1 (hu) |
| JP (1) | JP6169609B2 (hu) |
| KR (1) | KR102056041B1 (hu) |
| CN (1) | CN104053433A (hu) |
| AR (1) | AR089670A1 (hu) |
| AU (1) | AU2013206983B2 (hu) |
| BR (1) | BR112014016624A8 (hu) |
| CA (1) | CA2862497C (hu) |
| DK (1) | DK2800557T3 (hu) |
| ES (1) | ES2848534T3 (hu) |
| HK (1) | HK1201448A1 (hu) |
| HU (1) | HUE053063T2 (hu) |
| MX (1) | MX370218B (hu) |
| NZ (1) | NZ626672A (hu) |
| PH (1) | PH12014501446B1 (hu) |
| PL (1) | PL2800557T3 (hu) |
| WO (1) | WO2013103318A1 (hu) |
| ZA (1) | ZA201405745B (hu) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014157264A1 (ja) * | 2013-03-27 | 2014-10-02 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 口腔内崩壊性フィルムコーティング錠 |
| EP3003285B1 (en) * | 2013-06-03 | 2022-02-16 | McNeil AB | Solid pharmaceutical dosage form for release of at least two active pharmaceutical ingredients in the oral cavity |
| WO2015068058A1 (en) * | 2013-11-06 | 2015-05-14 | Rk Technology & Investments Pte. Ltd. | Tobacco free 'niconuts'and the process thereof |
| KR20170003926A (ko) * | 2014-04-08 | 2017-01-10 | 산사 코포레이션 (바베이도스) 인코포레이티드 | 니코틴 제형 및 이의 제조방법 |
| CN104489916B (zh) * | 2014-12-02 | 2016-06-01 | 云南中烟工业有限责任公司 | 红醋栗提取物在卷烟中的应用 |
| US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| US9585835B1 (en) | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
| MX2019000219A (es) | 2016-07-05 | 2019-09-04 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida. |
| BR112019023664A8 (pt) | 2017-05-22 | 2022-07-26 | Currahee Holding Company Inc | Forma de dosagem em pastilha |
| JP7278281B2 (ja) * | 2017-12-08 | 2023-05-19 | フェルティン ファルマ アー／エス | ニコチン錠 |
| MX2020005892A (es) * | 2017-12-08 | 2020-10-07 | Fertin Pharma As | Formulacion de nicotina oral solida. |
| US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US11883527B2 (en) | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US11889856B2 (en) | 2019-12-09 | 2024-02-06 | Nicoventures Trading Limited | Oral foam composition |
| CA3160750A1 (en) | 2019-12-09 | 2021-06-17 | Anthony Richard Gerardi | Oral product comprising a cannabinoid |
| SE544672C2 (en) * | 2020-05-07 | 2022-10-11 | Liw Innovation Ab | New compositions for oral or nasal use |
| US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
| US20220387328A1 (en) * | 2021-06-04 | 2022-12-08 | Glaxosmithkline Consumer Healthcare Holdings (Us) Llc | Dosage form for nicotine replacement therapy |
| US20230109240A1 (en) * | 2021-09-30 | 2023-04-06 | L'oreal | Compositions and methods for styling hair |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1219291A (en) * | 1910-12-13 | 1917-03-13 | Chester Earl Gray | Process of manufacturing products from milk and cream. |
| GB2230439A (en) * | 1989-04-20 | 1990-10-24 | Alec Stanley Walter Shaw | Nicotine lozenges |
| US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
| US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
| HU224035B1 (hu) * | 1996-05-13 | 2005-05-30 | Novartis Consumer Health S.A. | Bukkális adagolórendszer |
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| US6583160B2 (en) * | 1999-04-14 | 2003-06-24 | Steve Smith | Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
| JP4044709B2 (ja) * | 1999-11-19 | 2008-02-06 | 信越化学工業株式会社 | 水系フィルムコーティング剤及び経口固形製剤 |
| US6419956B1 (en) * | 1999-12-30 | 2002-07-16 | Ancile Pharmaceuticals | Odor-masking coating for a pharmaceutical preparation |
| US20020119196A1 (en) * | 2000-12-21 | 2002-08-29 | Narendra Parikh | Texture masked particles containing an active ingredient |
| SE0102197D0 (sv) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
| WO2003003957A1 (en) * | 2001-07-06 | 2003-01-16 | Lavipharm Laboratories Inc. | Quick dissolving oral mucosal drug delivery device with moisture barrier coating |
| JP5089840B2 (ja) * | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | ニコチン含有フィルム製剤 |
| US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
| SG108299A1 (en) * | 2002-06-11 | 2005-01-28 | Inst Data Storage | Method and apparatus for forming periodic structures |
| NO346973B1 (en) * | 2002-12-20 | 2023-03-20 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
| US20040151771A1 (en) * | 2003-02-04 | 2004-08-05 | Gin Jerry B. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
| US7022750B2 (en) * | 2003-04-04 | 2006-04-04 | Ppg Industries Ohio, Inc. | Anti-fouling coating containing copper and graphite |
| GB0320854D0 (en) * | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
| US20070269492A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
| US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
| US20080286341A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
| DK2293786T3 (en) * | 2008-05-21 | 2015-02-23 | Novartis Ag | Tabletable chewing gum comprising nicotine and a buffer |
| EP2296486B1 (en) * | 2008-05-26 | 2015-04-29 | Fertin Pharma A/S | Film-coated compressed chewing gum |
| RU2011119494A (ru) * | 2008-10-14 | 2012-11-27 | Макнейл Аб | Многокомпонентная интраоральная лекарственная форма препарата и ее применение |
| EP2233134A1 (en) * | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
| US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
| US20110268809A1 (en) * | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
-
2012
- 2012-01-23 US US13/355,768 patent/US20130177646A1/en not_active Abandoned
-
2013
- 2013-01-04 AR ARP130100043A patent/AR089670A1/es unknown
- 2013-01-07 CA CA2862497A patent/CA2862497C/en active Active
- 2013-01-07 ES ES13733926T patent/ES2848534T3/es active Active
- 2013-01-07 CN CN201380004947.3A patent/CN104053433A/zh active Pending
- 2013-01-07 MX MX2014008271A patent/MX370218B/es active IP Right Grant
- 2013-01-07 EP EP13733926.3A patent/EP2800557B1/en active Active
- 2013-01-07 AU AU2013206983A patent/AU2013206983B2/en active Active
- 2013-01-07 BR BR112014016624A patent/BR112014016624A8/pt not_active Application Discontinuation
- 2013-01-07 JP JP2014551222A patent/JP6169609B2/ja active Active
- 2013-01-07 DK DK13733926.3T patent/DK2800557T3/da active
- 2013-01-07 WO PCT/SE2013/050005 patent/WO2013103318A1/en active Application Filing
- 2013-01-07 KR KR1020147021906A patent/KR102056041B1/ko active IP Right Grant
- 2013-01-07 HU HUE13733926A patent/HUE053063T2/hu unknown
- 2013-01-07 PL PL13733926T patent/PL2800557T3/pl unknown
- 2013-01-07 NZ NZ626672A patent/NZ626672A/en unknown
-
2014
- 2014-06-23 PH PH12014501446A patent/PH12014501446B1/en unknown
- 2014-08-04 ZA ZA2014/05745A patent/ZA201405745B/en unknown
-
2015
- 2015-02-26 HK HK15101942.0A patent/HK1201448A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014008271A (es) | 2014-10-06 |
| AU2013206983B2 (en) | 2017-10-05 |
| CA2862497C (en) | 2020-04-14 |
| BR112014016624A8 (pt) | 2017-07-04 |
| DK2800557T3 (da) | 2021-02-15 |
| PL2800557T3 (pl) | 2021-06-14 |
| JP6169609B2 (ja) | 2017-07-26 |
| CN104053433A (zh) | 2014-09-17 |
| US20130177646A1 (en) | 2013-07-11 |
| CA2862497A1 (en) | 2013-07-11 |
| PH12014501446A1 (en) | 2014-10-08 |
| EP2800557A4 (en) | 2015-09-09 |
| EP2800557A1 (en) | 2014-11-12 |
| JP2015503581A (ja) | 2015-02-02 |
| WO2013103318A1 (en) | 2013-07-11 |
| KR102056041B1 (ko) | 2019-12-16 |
| MX370218B (es) | 2019-12-05 |
| RU2014132174A (ru) | 2016-02-27 |
| RU2623018C2 (ru) | 2017-06-21 |
| AR089670A1 (es) | 2014-09-10 |
| ZA201405745B (en) | 2016-06-29 |
| EP2800557B1 (en) | 2020-12-30 |
| KR20140108728A (ko) | 2014-09-12 |
| AU2013206983A1 (en) | 2014-07-03 |
| BR112014016624A2 (pt) | 2017-06-13 |
| PH12014501446B1 (en) | 2014-10-08 |
| NZ626672A (en) | 2016-11-25 |
| ES2848534T3 (es) | 2021-08-10 |
| HK1201448A1 (en) | 2015-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1201448A1 (en) | Solid nicotine-comprising dosage form with reduced organoleptic disturbance | |
| HK1204513A1 (en) | Quality-driven streaming | |
| EP2842467A4 (en) | ROASTER | |
| ZA201503358B (en) | Structure | |
| EP2867896A4 (en) | RHYTHM OF CONTENT | |
| IL273076A (en) | Solid dosage form | |
| GB201411223D0 (en) | None | |
| HK1198750A1 (zh) | 陀螺 | |
| GB201319035D0 (en) | Spolier structure | |
| EP2891518A4 (en) | CONTINUOUS PROCESSOR | |
| AP2014007896A0 (en) | Improved injections | |
| PL2734192T3 (pl) | Musująca postać dawkowana | |
| HUP1300640A2 (en) | Belt-mounting structure | |
| GB201218012D0 (en) | Dosage forms | |
| GB2535261B (en) | Fastened structure | |
| GB2500464B (en) | Toaster | |
| EP2871919A4 (en) | STRUCTURE | |
| GB2500883B (en) | Improved saw-horse | |
| GB201410091D0 (en) | None | |
| ZA201305187B (en) | Improved brattice | |
| AU347499S (en) | Top | |
| AU347497S (en) | Top | |
| AU347500S (en) | Top | |
| AU346943S (en) | Top | |
| AU346940S (en) | Top |